Usa Financial Portformulas Corp Ligand Pharmaceuticals Inc Transaction History

Usa Financial Portformulas Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $233,575 - $314,146	-2,205 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $283,033 - $600,046	2,205 New	2,205 $605,000
Q3 2018 Oct 31, 2018	SELL	$211.18 - $274.49 $116,149 - $150,969	-550 Closed	0 $0
Q1 2018 Apr 03, 2018	BUY	$138.63 - $182.62 $76,246 - $100,441	550 New	550 $91,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.